Pharmaceutical Reference Pricing: Does It Have a Future in the U.S.?

For reference pricing — where an insurer or employer establishes a maximum contribution it will make toward the price of a drug or procedure, and the patient pays the remainder — to work as intended, insurers must have up-to-date information on drug prices; patients and physicians must have access to the prices charged at different distribution sites and the prices for different drugs within each therapeutic class; and information on quality as well as price is needed.

       

Read the full post on The Commonwealth Fund